Physician profile
Anna Gomberg
NPI 1568473148
$2,116.32
in general payments reported to CMS, 2019-2025
11 companies · $369 in 2025
The $369 reported for 2025 was more than what a typical Child & Adolescent Psychiatry provider received nationally (typical 2025 total: $132).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $771 · 2020: $143 · 2022: $221 · 2023: $255 · 2024: $358 · 2025: $369.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $368.75 | 2025 | Cobenfy |
| Otsuka America Pharmaceutical, INC. | $358.39 | 2019-2022 | |
| Axsome Therapeutics, INC. | $346.48 | 2023-2024 | Auvelity |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $266.60 | 2023-2024 | Caplyta |
| Janssen Pharmaceuticals, INC | $193.75 | 2019 | |
| Sunovion Pharmaceuticals INC. | $138.68 | 2019-2020 | |
| Allergan, INC. | $125.00 | 2019 | |
| Jazz Pharmaceuticals INC. | $124.55 | 2019 | |
| Abbvie INC. | $96.29 | 2022 | |
| Shire North American Group INC | $75.90 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.93 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Gomberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.